BellumkondaLGulBMasriSC.Evolving concepts in diagnosis and management of cardiogenic shock. Am J Cardiol2018; 122: 1104–1110.
2.
AbramsDCombesABrodieD.Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. J Am Coll Cardiol2014; 63: 2769–2778.
3.
AbramsDGaranARAbdelbaryA, et al. Position paper for the organization of ECMO programs for cardiac failure in adults. Intensive Care Med2018; 44: 717–729.
4.
WangLYangFWangX, et al. Predicting mortality in patients undergoing VA-ECMO after coronary artery bypass grafting: the REMEMBER score. Crit Care2019; 23: 11.
5.
SchmidtMBurrellARobertsL, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J2015; 36: 2246–2256.
6.
MullerGFlecherELebretonG, et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med2016; 42: 370–378.
7.
CollinsGSReitsmaJBAltmanDG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD group. Circulation2015; 131: 211–219.
8.
LabarèreJRenaudBFineMJ.How to derive and validate clinical prediction models for use in intensive care medicine. Intensive Care Med2014; 40: 513–527.
9.
SullivanJBakESullivanMJ, et al. Predictive value of scoring tools in determining heparin-induced thrombocytopenia in patients on extracorporeal membrane oxygenation. Perfusion2020; 35: 378–383.
10.
PabstDSanchez-CuevaPASoleimaniB, et al. Predictors for acute and chronic renal failure and survival in patients supported with veno-arterial extracorporeal membrane oxygenation. Perfusion2020; 35: 402–408.
11.
XieHYangFHouD, et al. Risk factors of in-hospital mortality in adult postcardiotomy cardiogenic shock patients successfully weaned from venoarterial extracorporeal membrane oxygenation. Perfusion2020; 35: 417–426.
